World First! Prof. Lin Shen's Team's CAR-T Gastric Cancer RCT Featured on the Headlines of The Lancet and Nature

2025-6-11
阅读全文
Dr. Ke Xiaoyan / Dr. Hu Kai’s Team: Sequential CD19-20 CAR-T Therapy Improves Remission Rates and Significantly Prolongs Survival in R/R LBCL

2025-5-21
阅读全文
CD58 Serves as a Leukemia Marker in Heavily Treated R/R B-ALL Patients

2025-5-16
阅读全文
GoBroad Team Contributes Rare Cases to the EVOLVE Global Study, Systematically Unveiling Lineage Switch Characteristics in Leukemia

2025-4-15
阅读全文
Dr. LI Su: BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma

2025-4-1
阅读全文
Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study

2025-3-6
阅读全文
Five-year outcomes of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation

2025-1-22
阅读全文
CD7 CART Therapy Bridging Allo-HSCT Remarkably Improves Long-Term DFS in Refractory/Relapsed T-ALL/LBL

2024-12-11
阅读全文
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial

2024-10-10
阅读全文

血液系统疾病诊疗

实体肿瘤诊疗

优势诊疗技术

就诊指南

邮箱：international.service@gobroadhealthcare.com

电话：+86-010-50951957

地址：北京市丰台区丽泽金融商务区丽泽路20号丽泽SOHO南塔12层

扫码关注我们

北京高博医疗科技集团有限公司京公网安备 11010502037763号京ICP备19005517号-3

联系我们

邮箱：international.service@gobroadhealthcare.com

电话：+86-010-50951957

地址：北京市丰台区丽泽金融商务区丽泽路20号丽泽SOHO南塔12层

扫码关注我们

北京高博医疗科技集团有限公司京公网安备 11010502037763号京ICP备19005517号-3